Literature DB >> 15609003

Dendritic cell-mediated T cell polarization.

Esther C de Jong1, Hermelijn H Smits, Martien L Kapsenberg.   

Abstract

Effective defense against diverse types of micro-organisms that invade our body requires specialized classes of antigen-specific immune responses initiated and maintained by distinct subsets of effector CD4(+) T helper (Th) cells. Excessive or detrimental (e.g., autoimmune) responses by effector T cells are controlled by regulatory T cells. The optimal balance in the development of the different types of effector and regulatory Th cells is orchestrated by dendritic cells (DC). This review discusses the way DC adapt the T cell response to the type of pathogen, focusing on the tools that DC use in this management of the T cell response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15609003     DOI: 10.1007/s00281-004-0167-1

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


  134 in total

1.  PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.

Authors:  T Okazaki; A Maeda; H Nishimura; T Kurosaki; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

2.  Adenoviral-mediated overexpression of monocyte chemoattractant protein-1 differentially alters the development of Th1 and Th2 type responses in vivo.

Authors:  A Matsukawa; N W Lukacs; T J Standiford; S W Chensue; S L Kunkel
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

3.  Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: relationship to local inflammation, Th cell expression, and IL-12 production.

Authors:  S W Chensue; K S Warmington; J H Ruth; P S Sanghi; P Lincoln; S L Kunkel
Journal:  J Immunol       Date:  1996-11-15       Impact factor: 5.422

4.  Development of Th1-type immune responses requires the type I cytokine receptor TCCR.

Authors:  Q Chen; N Ghilardi; H Wang; T Baker; M H Xie; A Gurney; I S Grewal; F J de Sauvage
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

5.  Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes.

Authors:  Y Agata; A Kawasaki; H Nishimura; Y Ishida; T Tsubata; H Yagita; T Honjo
Journal:  Int Immunol       Date:  1996-05       Impact factor: 4.823

6.  Microbial recognition via Toll-like receptor-dependent and -independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering.

Authors:  Alexander D Edwards; Shivanthi P Manickasingham; Roman Spörri; Sandra S Diebold; Oliver Schulz; Alan Sher; Tsuneyasu Kaisho; Shizuo Akira; Caetano Reis e Sousa
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

7.  Commensal Gram-negative bacteria prime human dendritic cells for enhanced IL-23 and IL-27 expression and enhanced Th1 development.

Authors:  Hermelijn H Smits; Astrid J van Beelen; Christina Hessle; Robert Westland; Esther de Jong; Eelco Soeteman; Agnes Wold; Eddy A Wierenga; Martien L Kapsenberg
Journal:  Eur J Immunol       Date:  2004-05       Impact factor: 5.532

8.  IL-23 production by cosecretion of endogenous p19 and transgenic p40 in keratin 14/p40 transgenic mice: evidence for enhanced cutaneous immunity.

Authors:  Tamara Kopp; Petra Lenz; Concha Bello-Fernandez; Robert A Kastelein; Thomas S Kupper; Georg Stingl
Journal:  J Immunol       Date:  2003-06-01       Impact factor: 5.422

9.  Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.

Authors:  Y Ishida; Y Agata; K Shibahara; T Honjo
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

10.  Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation.

Authors:  Craig A Murphy; Claire L Langrish; Yi Chen; Wendy Blumenschein; Terrill McClanahan; Robert A Kastelein; Jonathon D Sedgwick; Daniel J Cua
Journal:  J Exp Med       Date:  2003-12-08       Impact factor: 14.307

View more
  101 in total

1.  Presentation of high antigen-dose by splenic B220(lo) B cells fosters a feedback loop between T helper type 2 memory and antibody isotype switching.

Authors:  Jason S Ellis; F Betul Guloglu; Habib Zaghouani
Journal:  Immunology       Date:  2016-01-28       Impact factor: 7.397

2.  Differences in T-helper polarizing capability between human monocyte-derived dendritic cells and monocyte-derived Langerhans'-like cells.

Authors:  Ivan Rajkovic; Ana Dragicevic; Sasa Vasilijic; Biljana Bozic; Tanja Dzopalic; Sergej Tomic; Ivana Majstorovic; Dragana Vucevic; Jelena Djokic; Bela Balint; Miodrag Colic
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

3.  mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS.

Authors:  Heth R Turnquist; Jon Cardinal; Camila Macedo; Brian R Rosborough; Tina L Sumpter; David A Geller; Diana Metes; Angus W Thomson
Journal:  Blood       Date:  2010-03-24       Impact factor: 22.113

Review 4.  Immunoregulation of dendritic cells.

Authors:  Mark A Wallet; Pradip Sen; Roland Tisch
Journal:  Clin Med Res       Date:  2005-08

Review 5.  Vaccines: all things considered.

Authors:  Ken S Rosenthal; Daniel H Zimmerman
Journal:  Clin Vaccine Immunol       Date:  2006-08

6.  Granulocyte/Macrophage Colony-stimulating Factor-dependent Dendritic Cells Restrain Lean Adipose Tissue Expansion.

Authors:  Nathalie Pamir; Ning-Chun Liu; Angela Irwin; Lev Becker; YuFeng Peng; Graziella E Ronsein; Karin E Bornfeldt; Jeremy S Duffield; Jay W Heinecke
Journal:  J Biol Chem       Date:  2015-04-30       Impact factor: 5.157

7.  CARMA3 Is Critical for the Initiation of Allergic Airway Inflammation.

Authors:  Benjamin Causton; Ravisankar A Ramadas; Josalyn L Cho; Khristianna Jones; Ana Pardo-Saganta; Jayaraj Rajagopal; Ramnik J Xavier; Benjamin D Medoff
Journal:  J Immunol       Date:  2015-06-03       Impact factor: 5.422

8.  Differential effects of hepatitis C virus JFH1 on human myeloid and plasmacytoid dendritic cells.

Authors:  Hua Liang; Rodney S Russell; Nicole L Yonkers; David McDonald; Benigno Rodriguez; Clifford V Harding; Donald D Anthony
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

9.  TGF-beta1 gene-modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4(+)Foxp3(+) regulatory T cells.

Authors:  Zhijian Cai; Wei Zhang; Min Li; Yinpu Yue; Fei Yang; Lei Yu; Xuetao Cao; Jianli Wang
Journal:  Cell Mol Immunol       Date:  2010-01       Impact factor: 11.530

10.  Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella.

Authors:  Jerome S Harms; Marina A Durward; Diogo M Magnani; Gary A Splitter
Journal:  J Immune Based Ther Vaccines       Date:  2009-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.